A method for designing and screening of mesophilic argonaute-based orthogonal circuits and application thereof
Patent Information
- Application Number
- CN202610662348.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-14
- Publication Date
- 2026-08-04
AI Technical Summary
然而,目前的方法尚未能在这些关键参数之间实现切实可行的平衡
本发明通过计算机辅助的数字序列设计(digital sequence designing, DSE)技术,用于筛选大量互补的、与CbAgo兼容的gDNA-target DNA(tDNA)配对,这些配对可在单次反应中独立或同时运作,从而避免不同gDNA物种之间的杂交。本发明还提供了一个交互式界面,支持通过可调节的设计参数进行序列辅助生成,从而能够根据特定的检测需求定制构建互补的环状序列集。通过利用CbAgo的可编程切割活性及其将切割产物用作新引导序列的能力, 我们构建了一个基于DSE技术的正交gDNA-tDNA-电路(GTC)平台,该平台无需引入额外的DNA扩增策略或多酶系统,即可实现报告探针1(reporter1, R1)与报告探针2(reporter2, R2)之间高度特异且呈指数级增长的多重信号转换。该平台将gDNA的内部和交叉杂交概率降低至1.6%以下,将序列交叉杂交干扰降至0.032%,同时将CbAgo介导的探针切割效率提高了高达157%。
Smart Images

Figure CN122511346A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to an orthogonal loop design and screening method based on mesophilic Argonaute and its application, belonging to the field of biosensing technology. Background Technology
[0002] Pathogen infections affect nearly one-tenth of the population, often caused by pathogens that infect humans through contaminated food, leading to serious health problems such as kidney failure, liver failure, neurological disorders, reactive arthritis, and cancer, and even death. Notably, multiple pathogens often coexist in real-world samples. Preventing and controlling foodborne disease outbreaks requires establishing highly sensitive, rapid, and multiplex detection systems for pathogens. Currently, the main methods for pathogen detection include plate culture, immunoassay, and real-time quantitative polymerase chain reaction (qPCR). Plate culture offers high selectivity and sensitivity, but results typically take several days. Furthermore, this method is difficult to apply to the simultaneous monitoring of multiple pathogens in complex food matrices. Immunoassay is easy to implement but limited by the high cost and insufficient sensitivity of antibodies. While qPCR offers high sensitivity, specificity, and multiplex detection capabilities, it requires well-equipped laboratories, trained personnel, and the amplification step increases the risk of aerosol contamination. Moreover, the simultaneous detection of multiple pathogens increases the risk of interference between recognition elements for different analytes and the risk of false alarms in the absence of the target analyte. These challenges highlight the urgent need to develop alternative detection tools that are fast, sensitive, specific, multi-detection, and easy to operate.
[0003] The prokaryotic Argonaute (Ago) protein system has revolutionized the field of pathogen diagnostics due to its single nucleotide specificity, high accuracy, and programmability. Most pAgos do not require an adjacent motif in the protospacer region and utilize guide DNA (gDNA) to specifically cleave complementary DNA strands between the 10th and 11th bases at the 5' end of the gDNA. These properties enable the design of a wide variety of gDNAs to guide the recognition and cleavage of pAgo-mediated complementary targets, providing significant advancements for multiplexing. Thermophilic types require high reaction temperatures (66–95 °C) for effective cleavage, limiting their application in point-of-care testing (POCT). In contrast, strains such as Clostridium butyricum Ago (… Clostridium butyricumRecent advances in mesophilic CbAgo (CbAgo) have made it a promising candidate for point-of-care testing (POCT) and biosensor applications due to its efficient operation under suitable temperature conditions. However, two major limiting factors hinder the widespread application of mesophilic CbAgo in food safety multiplex diagnostics. First, under mesophilic conditions, different gDNAs are more prone to cross-hybridization, which can interfere with the efficient loading of gDNA into mesophilic CbAgo and trigger unexpected complementary cleavage events between different gDNA species, thereby reducing the specificity and reliability of the assay. Second, the sensitivity of mesophilic CbAgo-based sensors is limited by factors such as the difficulty of gDNA regeneration and low enzyme utilization, often requiring additional DNA amplification strategies, which may increase operational complexity and the risk of aerosol contamination. An ideal mesophilic CbAgo-based multiplex detection method should combine high sensitivity, high specificity, multiplex detection capability, and ease of operation. However, current methods have not yet achieved a practical balance among these key parameters. Summary of the Invention
[0004] To address the shortcomings of the existing technologies, this invention provides an orthogonal loop design and screening method and its application based on mesophilic Argonaute, aiming to solve the technical problem of the current lack of mesophilic multiplex detection methods based on Argonaute that combine high sensitivity, high specificity, multiplex detection capability, and ease of operation.
[0005] The first technical solution provided by this invention is a screening method for compositions for multiplex detection, the method comprising the following steps: (1) Encode DNA bases using “A”, “T”, “C” and “G” as character codes, set from left to right in the 5’-3’ direction, and set length and G / C content as basic parameters; (2) Input the target sequence, randomly select candidate gDNA1 from the target sequence according to the basic parameters, and display them in 5'-3'; (3) The gDNA1 obtained in step (2) is used to determine the similarity by the forward continuous similarity calculation and the reverse continuous similarity calculation rules. If the similarity is high, the process is to return to (2) to re-screen gDNA1. (4) The gDNA1 obtained in step (3) is set as candidate G1 by the 10 nt bases in the 5'-3' direction and the 6 nt bases extending further to the 5' end in the target sequence; the gDNA1 is set as candidate G2 by the 6 nt bases in the 3'-5' direction and the 10 nt bases extending further to the 3' end in the target sequence; the similarity of all G1 and G2 is determined by the forward continuous similarity calculation and the reverse continuous similarity calculation rules. If the similarity is high, return to (3) to re-screen gDNA1. (5) After verification in step (4), the gDNA1 obtained is reversed in the 3'-5' direction and 6nt bases are randomly generated at the 3' end to obtain candidate R1. The 16nt bases in the 3'-5' direction of R1 are candidate gDNA2. Candidate gDNA2 is reversed in the 3'-5' direction and 6nt bases are extended at the 3' end of the gDNA1 sequence to obtain candidate R2. (6) The gDNA2 obtained in step (5) is used to determine the similarity by the forward continuous similarity calculation and the reverse continuous similarity calculation rules. If the similarity is high, return to (5) to re-screen R1. If it cannot be screened, (2) to re-screen gDNA1.
[0006] The second technical solution provided by this invention is a composition for simultaneously detecting Staphylococcus aureus, Salmonella, and Listeria monocytogenes, the composition comprising the following three groups of compositions: (1) The nucleic acid compositions G1.1, G2.1, R1.1, and R2.1 used for detecting Listeria monocytogenes, with nucleotide sequences as shown in SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, and SEQ ID NO.6, respectively; (2) The nucleic acid compositions G1.2, G2.2, R1.2, and R2.2 used for detecting Staphylococcus aureus, with nucleotide sequences as shown in SEQ ID NO.8, SEQ ID NO.9, SEQ ID NO.10, and SEQ ID NO.12, respectively; (3) The nucleic acid compositions G1.3, G2.3, R1.3 and R2.3 used for detecting Salmonella, with nucleotide sequences as shown in SEQ ID NO.14, SEQ ID NO.15, SEQ ID NO.16 and SEQ ID NO.18, respectively.
[0007] In some embodiments, R1.1, R1.2, and R1.3 are all mounted on the surface of polystyrene microspheres to obtain PS-R1.1, PS-R1.2, and PS-R1.3, respectively, and the amino acid sequences of PS-R1.1, PS-R1.2, and PS-R1.3 are as shown in SEQ ID NO.5, SEQ ID NO.12, and SEQ ID NO.17, respectively.
[0008] In some embodiments, the polystyrene microspheres of PS-R1.1, PS-R1.2, and PS-R1.3 have particle sizes and colors of 2μm white, 3μm white, and 3μm blue, respectively.
[0009] The third technical solution provided by the present invention is a detection system for simultaneously detecting Staphylococcus aureus, Salmonella and Listeria monocytogenes, wherein the detection system contains the composition described in the second technical solution.
[0010] In some embodiments, R1.1, R1.2, and R1.3 are all mounted on the surface of polystyrene microspheres to obtain PS-R1.1, PS-R1.2, and PS-R1.3, respectively, and the amino acid sequences of PS-R1.1, PS-R1.2, and PS-R1.3 are as shown in SEQ ID NO.5, SEQ ID NO.12, and SEQ ID NO.17, respectively.
[0011] In some embodiments, the polystyrene microspheres of PS-R1.1, PS-R1.2, and PS-R1.3 have particle sizes and colors of 2μm white, 3μm white, and 3μm blue, respectively.
[0012] In some embodiments, the detection system also contains Clostridium butyricum Ago protein and MNP-SA.
[0013] The fourth technical solution provided by the present invention is a reagent kit, which contains the composition described in the second technical solution or the detection system described in the fourth technical solution.
[0014] The fifth technical solution provided by the present invention is a mesophilic multiplex detection method based on CbAgo, wherein the method uses the detection system described in the third technical solution to detect Staphylococcus aureus, Salmonella and Listeria monocytogenes.
[0015] In some embodiments, the method includes the following steps: (1) G1.1, G1.2, G1.3, G2.1, G2.2, and G2.3 were pre-assembled in Tris-HCl and MnCl2 buffer (pH=8, 4 μL) for 15 minutes at 37 °C; target genomic DNA was added and the mixture was treated at 95 °C for 10 minutes. (2) Add PS-R1.1, PS-R1.2 and PS-R1.3 to the system in step (1), and incubate at 37 °C for 20 minutes. Then add MNP-SA, incubate at 37 °C for 20 minutes, and perform magnetic separation to obtain a suspension. (3) Place the suspension from step (2) into the imaging readout system and perform digital decoding. The number of microspheres with different particle sizes and colors is associated with different target concentrations to characterize the content of Staphylococcus aureus, Salmonella and Listeria monocytogenes in the target to be tested.
[0016] In some embodiments, in step (1), the final concentrations of G1.1, G1.2, G1.3, G2.1, G2.2, and G2.3 in the reaction system are all 0.2 μM.
[0017] In some embodiments, in step (1), the final concentration of CbAgo in the reaction system is 150 μg / mL.
[0018] In some embodiments, in step (2), the final concentrations of PS-R1.1, PS-R1.2, PS-R1.3, R2.1, R2.2, and R2.3 in the reaction system are 250 μg / mL, 375 μg / mL, 750 μg / mL, 0.2 μM, 0.2 μM, and 0.2 μM, respectively.
[0019] In some embodiments, in step (3), the final concentration of MNP-SA in the reaction system is 167 μg / mL.
[0020] Specifically, the testing steps are as follows: (1) G1 (G1.1, 1 μL, 4 μM; G1.2, 1 μL, 4 μM; G1.3, 1 μL, 4 μM), G2 (G1.1, 1 μL, 4 μM; G1.2, 1 μL, 4 μM; G1.3, 1 μL, 4 μM) and CbAgo (3 μL, 1 mg / mL) were pre-assembled for 15 minutes in Tris-HCl and MnCl2 buffer (pH=8, 4 μL) at 37 °C. Then 2 μL of genomic DNA was added.
[0021] (2) Add 5 μL of a mixture of PS-R1 (white PS-R1.1, 1 mg / mL; white PS-R1.2, 1.5 mg / mL; PS-R1.3, 3 mg / mL) and R2 (R2.1, 1 μL, 4 μM; R2.2, 1 μL, 4 μM; R2.3, 1 μL, 4 μM) and incubate at 37 °C for 20 minutes. Finally, add 10 μL of MNP-SA (500 μg / mL) and incubate at 37 °C for 20 minutes before magnetic separation.
[0022] (3) For the imaging readout system, 10 μL of the mixed suspension was placed on a glass slide, sealed with an 18 mm × 18 mm coverslip, and allowed to stand for 5 minutes. Bright-field images were captured using a 10× eyepiece and a 20× objective lens, along with Capture 2.4 software. For each concentration, ten regions were randomly selected for imaging, and all experiments were independently repeated three times. The acquired microscopic images were analyzed using a computer vision-based algorithm designed specifically for decoding particle size and color to quantitatively characterize the mixed microsphere population.
[0023] In short, the original RGB image is first converted to grayscale and binarized to generate a mask that selectively preserves target particles while suppressing background noise. Connected component analysis is then applied to identify individual objects and extract their bounding boxes. To ensure accurate identification of spherical particles, objects with aspect ratios deviating from circular features are excluded. Particles are then classified into predefined size categories (2000 nm, 3000 nm, 5000 nm, 6000 nm, and others) based on the width of each bounding box. For ease of visualization, objects belonging to different size groups are rendered in different pseudo-colors. Simultaneously, the average RGB brightness within each bounding box is calculated to distinguish between "white" and "blue" particles, thus achieving two-dimensional classification based on geometric dimensions and optical properties. The program automatically generates multiple output formats, including grayscale images, binarized masks, color-coded recognition images, and tabular statistical results. This workflow enables high-throughput, automated counting and classification of micrometer- and nanometer-sized particles under various imaging conditions.
[0024] The sixth technical solution provided by the present invention is the application of the composition described in the second technical solution, the detection system described in the third technical solution, or the kit described in the fourth technical solution in the in vitro detection of Staphylococcus aureus, Salmonella and Listeria monocytogenes.
[0025] Compared with the prior art, the beneficial effects of the present invention are as follows: This invention utilizes computer-aided digital sequence designing (DSE) technology to screen for a large number of complementary, CbAgo-compatible gDNA-target DNA (tDNA) pairs. These pairs can operate independently or simultaneously in a single reaction, thereby avoiding hybridization between different gDNA species. The invention also provides an interactive interface that supports sequence-assisted generation through adjustable design parameters, enabling the customized construction of complementary circular sequence sets according to specific detection needs. By leveraging the programmable cleavage activity of CbAgo and its ability to use cleavage products as novel guide sequences, we constructed an orthogonal gDNA-tDNA-circuit (GTC) platform based on DSE technology. This platform achieves highly specific and exponentially increasing multiple signal transductions between reporter probe 1 (R1) and reporter probe 2 (R2) without introducing additional DNA amplification strategies or multi-enzyme systems. This platform reduces the probability of internal and cross-hybridization of gDNA to below 1.6%, reduces sequence cross-hybridization interference to 0.032%, and increases CbAgo-mediated probe cleavage efficiency by up to 157%.
[0026] The composition obtained by using the above screening approach can achieve highly sensitive detection of pathogenic bacteria. In the detection of Staphylococcus aureus, Listeria monocytogenes and Salmonella typhimurium, the detection limits of the three strains reached 1 CFU / mL, 2 CFU / mL and 1 CFU / mL, respectively. Attached Figure Description
[0027] Figure 1 This is a schematic diagram of the orthogonal gDNA screening method of the present invention.
[0028] Figure 2 This invention addresses the problem of gDNA self-hybridization and cross-hybridization interference.
[0029] Figure 3 This invention addresses the problem of gDNA self-cleavage and cross-cleavage interference.
[0030] Figure 4 This invention adjusts the similarity parameter to ≤5 to determine the probability of gDNA cross-hybridization.
[0031] Figure 5 This is the principle of circuit construction described in this invention.
[0032] Figure 6 This is a schematic diagram of the computer-aided batch generation loop described in this invention.
[0033] Figure 7The simulated crossover probabilities of gDNA1 / R1 and gDNA2 / R2 generated in batches using computer-aided methods.
[0034] Figure 8 To evaluate the specificity of gDNA1 / R1 for experimental verification.
[0035] Figure 9 To evaluate the specificity of gDNA2 / R2 for experimental verification.
[0036] Figure 10 This is a schematic diagram of the modular construction described in this invention.
[0037] Figure 11 This invention describes the construction principle of applying the GTC platform to nucleic acid detection.
[0038] Figure 12 This is a schematic diagram of the interactive interface of the GTC platform for nucleic acid detection described in this invention.
[0039] Figure 13 The simulated independent existence probabilities of G1 / G2 generated for the GTC platform.
[0040] Figure 14 Simulated crossover probabilities of gDNA1 / R1 and gDNA2 / R2 generated for the GTC platform.
[0041] Figure 15 To evaluate the positive and negative results and loop effect in nucleic acid detection for experimental verification.
[0042] Figure 16 To evaluate the specificity of nucleic acid detection for experimental verification.
[0043] Figure 17 This is a schematic diagram of a microsphere coding and microscopic imaging system used for pathogen detection.
[0044] Figure 18 This is a schematic diagram illustrating the recognition principle based on machine vision.
[0045] Figure 19 Evaluation of the effectiveness of the circuits involved in the GTC platform for microsphere coding and microscopic imaging systems.
[0046] Figure 20 An evaluation of improving signal output efficiency is added to R2.
[0047] Figure 21 To evaluate the specificity of the GTC platform based on microsphere coding and microscopic imaging systems.
[0048] Figure 22 These are representative microscope images taken when detecting pathogenic bacteria at different concentrations.
[0049] Figure 23 To detect the linear relationship when different pathogens are detected.
[0050] Figure 24 To detect the specific number of particles when different concentrations of pathogenic bacteria are used.
[0051] Figure 25 To investigate the linear relationship in the detection of Staphylococcus aureus using a conventional CbAgo fluorescence sensor.
[0052] Figure 26 To test the recovery effect of spiking pathogens at different concentrations.
[0053] Figure 27 The principle of detecting pathogens in real samples.
[0054] Figure 28 To compare the effectiveness of different methods in detecting pathogens in real samples. Detailed Implementation
[0055] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.
[0056] Test method: 1. Cross-hybridization probability: Using commercial NUPACK nucleic acid simulation parameters, the reaction temperature was set to 37 °C, and Na... + and Mg 2+ The concentrations were set at 50 mM and 1 mM, respectively, and the concentrations of all DNA species were set at 1 μM.
[0057] 2. Validation of the detection of three pathogenic bacteria To verify the compatibility of the GTC platform, multidimensional encoded PS microspheres, and computer vision-based AI reading system in detecting pathogenic bacteria, three pathogenic bacteria were selected for analysis. Relevant sequences were generated by the GTC platform. Specifically, G1 (1 μL, 4 μM), G2 (1 μL, 4 μM), and CbAgo (1 μL, 1 mg / mL) were added to Tris-HCl and MnCl2 buffer (pH=8, 4 μL), respectively, and pre-assembled at 37 ℃ for 15 minutes. Subsequently, the genomic DNA was denatured at 95 ℃ for 10 minutes to open the double-stranded structure. Then, 2 μL of genomic DNA (10 mg / mL) was added to the test tube. 8CFU / mL was added and incubated at 37°C for 20 minutes. Then, 5 μL of PS-R1 (white PS2μm-R1.1, 1 mg / mL; white PS3μm-R1.2, 1.5 mg / mL; blue PS3μm-R1.3, 3 mg / mL) and R2 (R2.1, 1 μL, 4 μM; R2.2, 1 μL, 4 μM; R2.3, 1 μL, 4 μM) were added to a 3 μL buffer solution (pH=8) and incubated at 37°C for 20 minutes. Finally, 5 μL of MNP-SA (500 μg / mL) was added and diluted with deionized water to a final volume of 50 μL. Magnetic separation was performed after incubation at 37°C for 20 minutes. The number of particles with different encoding PS microspheres was detected by microscopy, and decoding was performed using a computer vision-based AI reading system.
[0058] 3. Specificity study for the detection of three pathogenic bacteria G1 (G1.1, 1 μL, 4 μM; G1.2, 1 μL, 4 μM; G1.3, 1 μL, 4 μM), G2 (G2.1, 1 μL, 4 μM; G2.2, 1 μL, 4 μM; G2.3, 1 μL, 4 μM), and CbAgo (3 μL, 1 mg / mL) were premixed in Tris-HCl and MnCl2 buffer (pH=8, 4 μL) and incubated at 37 °C for 15 min. Subsequently, the genomic DNA was denatured at 95 °C for 10 min to open the double-stranded structure. Next, 2 μL of genomic DNA (target: 10) was added to the tube. 6 CFU / mL; Interference: 10 8 The mixture was incubated at 37°C for 20 minutes. Then, 5 μL of a mixture of PS-R1 (white PS2μm-R1.1, 1 mg / mL; white PS3μm-R1.2, 1.5 mg / mL; blue PS3μm-R1.3, 3 mg / mL) and R2 (R2.1, 1 μL, 4 μM; R2.2, 1 μL, 4 μM; R2.3, 1 μL, 4 μM) was added and incubated at 37°C for 20 minutes. Finally, 10 μL of LMNP-SA (500 μg / mL) was added, and magnetic separation was performed after incubation at 37°C for 20 minutes. The number of particles in the different encoded PS microspheres was detected by microscopy, and decoding was performed using a computer vision-based AI reading system.
[0059] The raw materials used in the examples were as follows: white PS microspheres with a diameter of 2 / 3 μm (solid content: 100 mg / mL) and MNPs with a diameter of 180 nm (solid content: 10 mg / mL) modified with carboxylic acid were purchased from Bangs Laboratories. Blue PS microspheres with a diameter of 3 μm (solid content: 25 mg / mL) modified with carboxylic acid were purchased from Big Goose. Streptavidin (SA), N-hydroxysulfosuccinimide (NHS), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), TRIS hydrochloride (Tris-HCl), and manganese chloride (MnCl2) were all purchased from Sigma-Aldrich. Deionized water was prepared using a microporous Milli-Q ion exchange apparatus (Millipore). All nucleic acid sequences used in this study were purchased from Sangen Biosciences. qPCR kits were purchased from Bio-Rad Laboratories. Fish samples were collected from a market in Wuhan, China. Clinical samples were collected from the Central Theater Command General Hospital (Wuhan, China). This study has been approved by the Medical Ethics Committee of the Central Theater Command General Hospital (2023-026-01) and the requirement for informed consent has been waived.
[0060] Example 1: Orthogonal gDNA Screening Strategy An orthogonal gDNA screening strategy, such as Figure 1 As shown, this includes encoding base types, confirming screening conditions, and designing and screening batches of orthogonal gDNA using computers. The specific computational logic is as follows: (1) Input the user-defined DNA sequence length into the program, and obtain candidate DNA sequence A through random base generation rules (random combination of A, T, C, G); (2) The candidate DNA sequence A obtained in step (1) is calculated according to the GC content calculation rules:
[0061] Obtain the GC content percentage of the sequence, where NC represents the number of C bases, NG represents the number of G bases, and Ntotal represents the total number of bases; (3) The GC content results obtained in step (2) are used to obtain DNA sequence A that meets the conditions by setting the GC range screening rules (40% ≤ GC ≤ 60%); (4) The DNA sequence A obtained in step (3) is used to obtain the reverse sequence B through the sequence reverse arrangement operation rules; (5) The reverse sequence B obtained in step (4) is processed according to the base pairing rule (A T, C G) Obtain the complementary sequence C; (6) The DNA sequence A obtained in step (3) and the complementary sequence C obtained in step (5) are compared by the continuous base repetition detection rule to obtain the detection result of whether there are ≥6 consecutive identical bases; (7) The detection results obtained in step (6) are used to eliminate sequences with continuous repeating bases by self-complementation screening rules to obtain candidate DNA sequences that meet low self-complementation. (8) The candidate DNA sequence obtained in step (7) is compared with all complementary sequences C in the established DNA sequence library by the cross-sequence continuous repeat detection rule to obtain the detection result of whether there are ≥6 consecutive identical bases; (9) The detection results obtained in step (8) are used to remove sequences with high repetition regions by orthogonality screening rules to obtain a set of DNA sequences that satisfy orthogonality; (10) The DNA sequence set obtained in step (9) is generated by iterative generation rules, repeating steps (1) to (9) until the number of DNA sequences set by the user is reached; (11) The DNA sequence set obtained in step (10) is used to generate a result file containing sequence number, DNA sequence and GC content information by writing rules in CSV format.
[0062] In short, based on the mechanism of CbAgo, the gDNA selection length needs to be designed to be 16 nt, and the G / C percentage should be set between 30% and 70%. Simultaneously, to ensure the orthogonality of the gDNA, the similarity should be set to ≤6 nt, where similarity refers to the similarity of the gDNA itself and the similarity between different gDNAs. Similarity screening is mainly to avoid two possible situations under mesophilic conditions: one is that gDNA self-hybridization or cross-hybridization may make it difficult for the gDNA to integrate with CbAgo, thus hindering the cleavage reaction. Figure 2 Another reason is that the high similarity between gDNA itself or between different gDNAs leads to incorrect cleavage of gDNA mediated by the CbAgo / gDNA complex, resulting in signal distortion. Figure 3 Under these screening conditions, DSE can generate 100 gDNAs within 5 seconds (as shown in Table 1) and ensure that the cross-hybridization probability among these 100 gDNAs is <3.3%. If the similarity is set to ≤5nt, the cross-hybridization probability can be reduced to 1.6%. Figure 4 ).
[0063] Table 1. gDNA1 sequence generated by DSA.
[0064]
[0065] Example 2 Orthogonal Cutting Circuit Design Screening Strategy An orthogonal cutting circuit design screening strategy is as follows Figure 5 shown, and the specific design logic is as follows: (1) Import multiple gDNA sequences input by the user into the program, and obtain an independent set of gDNA sequences through string splitting rules; (2) The set of gDNA sequences obtained in step (1) is screened through sequence length determination rules to obtain standard gDNA sequences with a length of 16 nt; (3) The standard gDNA sequences obtained in step (2) are calculated through the GC content calculation rule:
[0066] Obtain the GC content percentage of the sequence, where NC represents the number of C bases, NG represents the number of G bases, and Ntotal represents the total number of bases; (4) The GC content results obtained in step (3) are screened through the GC range screening rule (40% < GC < 60%) to obtain eligible gDNA sequences; (5) The gDNA sequences obtained in step (4) are obtained through the reverse arrangement operation rule to obtain reverse gDNA sequences; (6) The reverse gDNA sequences obtained in step (5) are obtained through the base complementary pairing rule (A T, C G) to obtain the R1 complementary region sequence; (7) The R1 complementary region sequence obtained in step (6) randomly generates a 6 nt N sequence through the random base generation rule; (8) The 6 nt N sequence obtained in step (7) and the R1 complementary region sequence obtained in step (6) are spliced through the sequence splicing rule to obtain the R1 sequence; (9) The R1 sequence obtained in step (8) obtains the GC content of the R1 terminal region through the terminal 16 nt GC content calculation rule; (10) The GC content results obtained in step (9) are screened through the GC range screening rule (40% < GC < 60%) to obtain R1 sequences that meet the conditions; (11) The 6 nt N sequence obtained in step (7) obtains the reverse structure of the N sequence through the reverse arrangement operation rule; (12) The reverse structure of the N sequence obtained in step (11) obtains the M sequence through the base complementary pairing rule (A T, C G); (13) The M sequence obtained in step (12) and the gDNA sequence obtained in step (4) are spliced through the sequence splicing rule to obtain the R2 sequence; (14) The R1 sequence obtained in step (10) and the R2 sequence obtained in step (13) are used to generate nucleic acid sequences in the formats of 5'-R1-3' and 5'-R2-3' respectively, according to the formatted output rules; (15) The set of all R1 / R2 sequences obtained in step (14) is used to generate a result file containing group number, gDNA sequence, R1 sequence and R2 sequence information by writing rules in a CSV file.
[0067] In summary, by leveraging the property that CbAgo / gDNA cleavage substrates can continue to generate single-stranded DNA with a 5' phosphate group, substrate R1 was rationally designed to continue generating gDNA2 under CbAgo / gDNA1 cleavage. Based on this, substrate R2 was further designed to regenerate gDNA1 under CbAgo / gDNA2 cleavage, thus achieving gDNA1 regeneration. Then, parameters were further designed based on the above mechanism; specifically, the R1 / R2 length was set to 22 nt, and the G / C% was set between 30% and 70%. Figure 6 Under this design condition, 50 sets of gDNA1, R1 (containing gDNA2), and R2 sequences were generated simultaneously, as shown in Table 2. The simulation results show that the cross-hybridization probability of gDNA1 and R1 is <0.032%, and the cross-hybridization probability of gDNA2 and R2 is <0.013%. Figure 7 ).
[0068] Table 2. R1 and R2 sequences generated by GTC.
[0069]
[0070] Furthermore, five sequences were selected from the database (Table 3), and the fluorescence signal of the cleavage reaction was read by modifying the ends of R1 with the fluorescent group FAM and the fluorescence quencher group BHQ1, respectively. The specific reaction system was as follows: The extracted genomic DNA was first denatured at 95 °C for 20 min to unwind into single-stranded DNA, and then placed on ice. At the same time, G1 (2 μL, 2 μM), G2 (2 μL, 2 μM), and CbAgo (1 μL, 1 mg / mL) were added to Tris-HCl and MnCl2 buffer (pH=8, 4 μL), and pre-assembled at 37 °C for 10 min. Then, 2 μL of genomic single-stranded DNA was added, and incubated at 37 °C for 20 min. Subsequently, R1 (2 μL, 2 μM) and R2 (2 μL, 2 μM) were added to the buffer solution (pH=8, 10 μL), and the mixture was incubated at 37 °C for 20 minutes. The fluorescence signal was then read using a SpectraMax® iD3 multi-functional microplate reader.
[0071] To evaluate the orthogonality of the GTC platform, five different sequence sets generated by the GTC platform were selected (Table 3). The extracted genomic DNA was first denatured at 95 °C for 20 min to unwind into single-stranded DNA, and then placed on ice. Simultaneously, G1 (2 μL, 2 μM), G2 (2 μL, 2 μM), and CbAgo (1 μL, 1 mg / mL) were added to Tris-HCl and MnCl2 buffer (pH=8, 4 μL) and pre-assembled at 37 °C for 10 min. Then, 2 μL of genomic single-stranded DNA was added and incubated at 37 °C for 20 min. Subsequently, R1 (2 μL, 2 μM) and R2 (2 μL, 2 μM) were added to buffer (pH=8, 10 μL), and incubated at 37 °C for 20 min. Fluorescence signals were then read using a SpectraMax® iD3 multi-functional microplate reader.
[0072] First, the compatibility between gDNA1 and R1 within each sequence group was verified. Specifically, fluorescence assays were performed by changing the type of gDNA1 in the reaction system while keeping the R1 sequence constant. Subsequently, the compatibility between gDNA1, R1, and R2 within each group was evaluated by changing the R2 sequence and performing fluorescence analysis while keeping gDNA1 and R1 constant.
[0073] The results showed that different gDNA1s could only activate the cleavage of the corresponding R1 and produce a significant fluorescent signal. Figure 8 ), and different R2s can only activate the corresponding group of cyclic cleavage reactions ( Figure 9 This demonstrates the good applicability of the screening strategy. Modularizing the strategy design can greatly broaden its versatility. Figure 10 ).
[0074] Table 3. Experimental verification sequence
[0075] Example 3 Loop design screening strategies for pathogenic bacteria nucleic acid detection, such as Figure 11 As shown, the specific operation logic is as follows: (1) Import multiple initial DNA sequences S input by the user into the program and obtain an independent set of S sequences through string segmentation rules; (2) The set of S sequences obtained in step (1) is filtered according to the sequence length determination rule to obtain the set that satisfies: LS≥14+LT+14 is a valid initial sequence, where LS is the total length of the target sequences to be screened, and LT is the undetermined gDNA1 sequence with a default length of 16 nt. (3) The effective initial sequence obtained in step (2) is used to randomly extract a 16 nt segment from the sequence according to the random starting point selection rule to obtain the target sequence T; (4) The target sequence T obtained in step (3) is calculated according to the GC content calculation rules:
[0076] Obtain the GC content percentage of the sequence, where NC represents the number of C bases, NG represents the number of G bases, and Ntotal represents the total number of bases; (5) The GC content results obtained in step (4) are used to obtain T sequences that meet the conditions by using the GC range screening rule (40% ≤ GC ≤ 60%). (6) The T sequence obtained in step (5) is spliced together with the 10 nt downstream sequence of the last 6 nt of the T sequence according to the sequence splicing rules to obtain the G1′ sequence; (7) The T sequence obtained in step (5) is spliced with the upstream 6 nt sequence and the front 10 nt sequence according to the sequence splicing rules to obtain the G2′ sequence; (8) The G1′ sequence obtained in step (6) is analyzed according to the base pairing rule (A T, C G) Obtain the complementary sequence G1″; (9) The G2′ sequence obtained in step (7) is analyzed according to the base pairing rule (A T, C G) Obtain the complementary sequence G2″; (10) The complementary sequence of G1″ obtained in step (8) is used to obtain the G1 sequence through the reverse permutation operation rule; (11) The complementary sequence of G2″ obtained in step (9) is used to obtain the G2 sequence through the reverse permutation operation rule; (12) The G1 sequence obtained in step (10) is used to obtain the G1-C sequence through reverse permutation and complementary pairing operation rules; (13) The G2 sequence obtained in step (11) is used to obtain the G2-C sequence through reverse permutation and complementary pairing operation rules; (14) The G1 sequence obtained in step (10) and the G1-C sequence obtained in step (12) are compared by the rule of continuous identical base detection to obtain the continuous repeating base results between G1 and G1-C; (15) The G2 sequence obtained in step (11) and the G2-C sequence obtained in step (13) are compared by the rule of continuous identical base detection to obtain the continuous repeating base results between G2 and G2-C; (16) The detection results obtained in steps (14) and (15) are used to remove sequences with ≥8 consecutive identical bases by similarity screening rules to obtain G1 / G2 sequences with low self-complementarity; (17) The GC content of each sequence is obtained by using the GC content calculation rules for the G1 sequence obtained in step (10) and the G2 sequence obtained in step (11); (18) The GC content results obtained in step (17) are used to obtain G1 / G2 sequences that meet the conditions by using the GC range screening rule (30% ≤ GC ≤ 60%). (19) The multiple sets of G1 / G2 sequences obtained in step (18) are compared with G1 and G2-C and G2 and G1-C of different sequences by cross-sequence similarity detection rules to obtain the sequence similarity results; (20) The similarity results obtained in step (19) are used to eliminate sequence combinations with ≥8 consecutive identical bases by orthogonality optimization rules, thereby obtaining a sequence set that satisfies low cross complementarity; (21) The sequence set obtained in step (20) is used to repeat steps (3) to (20) through iterative optimization rules until a combination of T, G1 and G2 sequences that meet the conditions is obtained; (22) The final sequence combination obtained in step (21) is used to generate a result set containing T sequence, G1 sequence, G2 sequence and their GC content information through the result output rules.
[0077] In summary, based on the loop designs of Examples 1 and 2, the initial cleavage event, i.e., the conversion of pathogenic bacterial nucleic acid information into gDNA1 information via CbAgo cleavage guided by G1 and G2, is further incorporated into the design framework to achieve batch generation of G1, G2, gDNA1, R1, gDNA2, and R2 sequence sets for pathogenic bacterial nucleic acid detection. Figure 11 The specific steps are as follows: (1) Encode DNA bases using “A”, “T”, “C” and “G” as character codes, set from left to right in the 5’-3’ direction, and set length and G / C content as basic parameters.
[0078] (2) Input the target sequence, randomly select candidate gDNA1 from the target sequence according to the basic parameters, and display them in 5'-3'; (3) The gDNA1 obtained in step (2) is used to determine the similarity by the forward continuous similarity calculation and the reverse continuous similarity calculation rules. If the similarity is high, the process is to return to (2) to re-screen gDNA1. (4) The gDNA1 obtained in step (3) is used as candidate G1 by setting 10 nt bases in the 5'-3' direction and 6 nt bases extending further to the 5' end of the target sequence. The gDNA1 is used as candidate G2 by setting 6 nt bases in the 3'-5' direction and 10 nt bases extending further to the 3' end of the target sequence. The similarity of all G1 and G2 is determined by the forward continuous similarity calculation and the reverse continuous similarity calculation rules. If the similarity is high, the process returns to (3) to re-screen gDNA1. (5) After verification in step (4), the gDNA1 obtained is reversed in the 3'-5' direction and 6nt bases are randomly generated at the 3' end to obtain candidate R1. The 16nt bases in the 3'-5' direction of R1 are candidate gDNA2. Candidate gDNA2 is reversed in the 3'-5' direction and 6nt bases are extended at the 3' end of the gDNA1 sequence to obtain candidate R2. (6) The gDNA2 obtained in step (5) is used to determine the similarity by the forward continuous similarity calculation and the reverse continuous similarity calculation rules. If the similarity is high, return to (5) to re-screen R1. If it cannot be screened, (2) to re-screen gDNA1.
[0079] At the same time, based on this design strategy, an interactive webpage was built to lower the barrier to entry and make it available to other researchers. Figure 12 Specifically: (1) Construct the homepage of the GTC platform webpage and obtain a visual interface including a title bar, parameter input area, result display area and function tabs through HTML page structure and CSS interface rendering rules; (2) The webpage interface obtained in step (1) is used to establish a tab switching control rule: ① gDNA Screening module; ② Orthogonal Circuit module; ③ Nucleic Acid Detection module; This allows for switching between different functional pages; (3) The gDNA Screening module obtained in step (2) receives the rules input by the user: ① Number of generated sequences; ② Sequence length; ③ GC content range; ④ Threshold for continuous repetition; Obtain the set of gDNA screening parameters; (4) The set of gDNA screening parameters obtained in step (3) is used to generate candidate gDNA sequences through random base generation rules; (5) The candidate gDNA sequences obtained in step (4) are calculated according to the GC content calculation rules:
[0080] Obtain the GC content percentage of the sequence, where NC represents the number of C bases, NG represents the number of G bases, and Ntotal represents the total number of bases; (6) The GC content results obtained in step (5) are used to obtain gDNA sequences that meet the conditions through the GC range screening rules; (7) The gDNA sequences obtained in step (6) are screened out by sequence uniqueness and duplication detection rules to remove sequences with long continuous repeat regions, and an orthogonal gDNA sequence set is obtained. (8) The orthogonal gDNA sequence set obtained in step (7) is used to generate a result display interface containing sequence number, DNA sequence and GC content information according to the result display rules; (9) The result display interface obtained in step (8) generates a downloadable gDNA result file through the CSV export rules; (10) The Orthogonal Circuit module obtained in step (2) receives multiple 16 ntgDNA sequences through user input rules to obtain the circuit design input sequence set; (11) The set of gDNA sequences obtained in step (10) is used to obtain gDNA sequences that meet the GC conditions through GC content calculation and range screening rules; (12) The gDNA sequence obtained in step (11) is used to obtain the R1 complementary region sequence through the reverse complementarity operation rule; (13) The R1 complementary region sequence obtained in step (12) is used to obtain the R1 sequence through the random N6 sequence splicing rule; (14) The R1 sequence obtained in step (13) is used to obtain the M6 sequence through the reverse complementary operation rule; (15) The M6 sequence obtained in step (14) and the gDNA sequence obtained in step (11) are used to obtain the R2 sequence through sequence splicing rules; (16) The R1 / R2 sequences obtained in step (15) are used to obtain a set of orthogonal circuit sequences that meet the conditions through the GC content verification rules; (17) The set of orthogonal circuit sequences obtained in step (16) is used to generate a display interface containing the following three sets of information according to the result display rules: ① gDNA sequence; ② R1 sequence; ③ R2 sequence; (18) The Nucleic Acid Detection module obtained in step (2) receives the target DNA sequence set, GC content range and similarity threshold parameters through user input rules, and obtains the set of nucleic acid detection design parameters; (19) The set of nucleic acid detection design parameters obtained in step (18) is used to extract a 16 nt fragment from the target DNA sequence using the random site truncation rule to obtain the gDNA1 sequence; (20) The gDNA1 sequence obtained in step (19) is used to obtain the G1′ and G2′ sequences by the upstream and downstream sequence splicing rules; (21) The G1′ and G2′ sequences obtained in step (20) are used to obtain the G1 sequence and G2 sequence respectively through the reverse complementary operation rule; (22) The G1 and G2 sequences obtained in step (21) are used to obtain G1 / G2 sequences that meet the GC conditions through the GC content screening rules; (23) The G1 / G2 sequence obtained in step (22) is used to detect whether there are ≥8 consecutive identical base regions by the sequence self-complementary similarity detection rule; (24) The similarity detection results obtained in step (23) are used to obtain the G1 / G2 sequence combination that satisfies low self-complementarity through the low complementarity screening rule; (25) The multiple G1 / G2 sequence combinations obtained in step (24) are compared with the continuous repeating bases of G1 and G2-C and G2 and G1-C in different groups by cross-sequence cross-detection rules to obtain the orthogonality results between sequences; (26) The orthogonality results between sequences obtained in step (25) are repeatedly generated and filtered through the cyclic optimization rule until a sequence combination that satisfies low cross complementarity is obtained; (27) The final detection sequence combination obtained in step (26) is further called by the Orthogonal Circuit module to generate the corresponding R1 / R2 circuit sequence through the linkage circuit generation rule; (28) The detection sequence and circuit sequence obtained in step (27) are used to generate a result display rule that includes: ① gDNA1 sequence; ② G1 sequence; ③ G2 sequence; ④ R1 sequence; ⑤ R2 sequence; The interface for nucleic acid detection results, including GC content information; (29) The web page system obtained in step (1) displays the "Processing sequences" prompt message during the sequence calculation process by loading animation control rules; (30) The prompt information obtained in step (29) is used to provide error prompts for situations such as empty input, length not meeting requirements, GC content exceeding the range, and inability to generate a sequence that meets the conditions, through error handling rules; (31) The error messages and result display information obtained in step (30) are updated in real time in the web page result area through dynamic HTML rendering rules, thereby completing the online sequence design and orthogonal circuit construction process of the GTC platform.
[0081] by Listeria monocytogenes ( L. monocytogenes ), Staphylococcus aureus ( S. aureus ), and Salmonella typhimurium (S. typhimurium) Taking the example of sequence filtering, the obtained sequences are shown in Table 4.
[0082] To synthesize polystyrene microspheres-R1 (PS-R1), 40 μL of 2 / 3 / 6 µm white and 3 / 5 µm blue carboxylated polystyrene microspheres (PS; 100 mg / mL) were first washed twice with 0.01 M MES (2-(N-morpholino)ethanesulfonic acid) solution (hereinafter referred to as MEST) containing 0.05% Tween-20 at pH 6.0. Subsequently, 70 μL of EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, 5 mg / mL) and 35 μL of NHS (N-hydroxysuccinimide, 5 mg / mL) were added to the microspheres, and the mixture was diluted to a final volume of 1000 μL with MES (0.01 M, pH 6.0). The resulting solution was shaken at 37 °C for 20 min. After incubation, the mixture was centrifuged at 9000 rpm for 5 min to remove excess EDC and NHS. Subsequently, the activated carboxylated PS microspheres were suspended in 1000 μL of PBS (0.01 M, pH 7.4) containing the R1 sequence (10 μL, 100 μM). The mixture was incubated at 37 °C for 4 hours. The mixture was then washed with PBST (0.01 M PBS containing 0.05% Tween-20, pH 7.4) to remove any unreacted R1 sequence, and then incubated at 4 °C with 5% (w / w) BSA solution for 12 hours. Finally, the PS-R1 was washed and stored in PBS at 4 °C for subsequent use.
[0083] Simulation results show that no cross-hybridization occurs between different G1 and G2 strains under single-tube conditions. Figure 13 Furthermore, no cross-hybridization occurs between different gDNA1 and R1, or between different gDNA2 and R2. Figure 14 Furthermore, by modifying R1 with fluorescent and fluorescent quenching groups at both ends for fluorescence signal readout in the cleavage reaction, the results showed that different sequence groups could all produce fluorescent responses to the corresponding pathogens and could all activate the cyclic cleavage reaction. Figure 15 Extracted L. monocytogenes , S. aureus , and S. typhimuriumGenomic DNA was first denatured at 95 °C for 20 minutes to unwind into single-stranded DNA, and then placed on ice. Simultaneously, G1 (2 μM) and G2 (2 μM) for different target compounds were mixed with CbAgo and added to Tris-HCl and MnCl2 buffer (pH=8), and premixed at 37 °C for 10 minutes. Then, 2 μL of genomic single-stranded DNA was added, and incubated at 37 °C for 20 minutes. Subsequently, R1 (2 μM) and R2 (2 μM) for different target compounds were added, and incubated at 37 °C for 20 minutes, during which fluorescence signals were read.
[0084] Simultaneously, G1 (G1.1, 1 μL, 4 μM; G1.2, 1 μL, 4 μM; G1.3, 1 μL, 4 μM), G2 (G2.1, 1 μL, 4 μM; G2.2, 1 μL, 4 μM; G2.3, 1 μL, 4 μM), and CbAgo (3 μL, 1 mg / mL) were premixed in Tris-HCl and MnCl2 buffer (pH=8, 4 μL) and incubated at 37 °C for 15 min. Subsequently, the genomic DNA was denatured at 95 °C for 10 min to open the double-stranded structure. Then, 2 μL of genomic DNA (target: 10) was added to the tube. 6 CFU / mL; Interference: 10 8 CFU / mL was added and incubated at 37°C for 20 minutes. Subsequently, 5 μL of a mixture of R1 (2 μL, 2 μM) and R2 (R2.1, 1 μL, 4 μM; R2.2, 1 μL, 4 μM; R2.3, 1 μL, 4 μM) was added, and incubated at 37°C for 20 minutes. The results showed that the generated sequence set was highly specific and did not produce a signal response in interfering bacteria, demonstrating the good applicability of this screening strategy. Figure 16 ).
[0085] Table 4. Detection sequences for pathogenic bacteria
[0086] Example 4 The GTC system is combined with a microscopic imaging system for pathogen detection; the detection principle is as follows: Figure 17As shown, by attaching R1 from Table 4 to the surface of polystyrene (PS) microspheres and modifying the other end with biotin, R1 on the PS microsphere surface is cleaved after a CbAgo-mediated cleavage event, releasing the biotin into the solution. Then, streptavidin-labeled magnetic particles (MNP-SA) are further added. After R1 is cleaved, the PS microspheres cannot bind to the MNP-SA. The detection of different target analytes can be achieved by analyzing the number of microspheres remaining in the supernatant after magnetic separation. Figure 17 The supernatant microspheres were decoded using machine vision-based microscopic imaging technology to correlate the number of microspheres of different sizes and colors with different target concentrations. Figure 18 ).
[0087] The specific testing steps are as follows: G1 (1 μL, 4 μM), G2 (1 μL, 4 μM), and CbAgo (1 μL, 1 mg / mL) were added to Tris-HCl and MnCl2 buffer (pH=8, 4 μL), respectively, and pre-assembled at 37 °C for 15 min. Subsequently, the genomic DNA was denatured at 95 °C for 10 min to open the double-stranded structure. Then, 2 μL of genomic DNA (10 mg / mL) was added to the test tube. 8 CFU / mL was added and incubated at 37°C for 20 minutes. Then, 5 μL of PS-R1 (white PS2μm-R1.1, 1 mg / mL; white PS3μm-R1.2, 1.5 mg / mL; blue PS3μm-R1.3, 3 mg / mL) and R2 (R2.1, 1 μL, 4 μM; R2.2, 1 μL, 4 μM; R2.3, 1 μL, 4 μM) were added to a 3 μL buffer solution (pH=8) and incubated at 37°C for 20 minutes. Finally, 5 μL of MNP-SA (500 μg / mL) was added and diluted with deionized water to a final volume of 50 μL. After incubation at 37°C for 20 minutes, magnetic separation was performed. The number of particles with different encoded PS microspheres was detected by microscopy, and decoding was performed using a computer vision-based AI reading system. The experimental results showed that different sequence groups could all respond to pathogenic bacteria and could all activate cyclic cleavage reactions (CFU / mL). Figure 19 The addition of cyclic cutting increased the signal value by 109%-168%. Figure 20 This demonstrates the good compatibility between the GTC system and the microscopic imaging system. Furthermore, the experimental results show that the generated sequence sets are highly specific; the detection sequence sets corresponding to different bacteria only produce signal responses for that specific bacterium, and interfering bacteria do not affect the signal generation of that bacterium. Figure 21 ).
[0088] This method is responsive to different concentrations of pathogenic bacteria. Figure 22), in 10 1 -10 7 CFU / mL exhibits a good linear response ( L. monocytogenes : Y = 166.7X - 79.90, R2=0.98, LOD=1 CFU / mL; S. aureus : Y= 109.7X - 62.52, R2=0.98, LOD=2 CFU / mL; and S. typhimurium : Y = 94.76X -49.86, R2=0.98, LOD=1 CFU / mL; Figure 23 ), response concentration as low as 10 0 CFU / mL Figure 24 ).right L. monocytogenes , S. aureus and S. typhimurium The detection limits were 1 CFU / mL, 2 CFU / mL, and 1 CFU / mL, respectively. The proposed method reduces the minimum quantitation concentration by 1000 times compared to traditional fluorescence-based CbAgo sensors. Figure 25 ).
[0089] To verify the effectiveness of multiplex detection, three different concentrations of three pathogenic bacteria were added to the negative sample. L. monocytogenes , S. aureus and S. typhimurium 10², 10³ and 10 4 Recovery was tested for CFU / mL. Specifically, 10 CFU / mL values were set up. 2 10 3 and 10 4 Three groups of spiked samples were prepared by adding G1 (1 μL, 4 μM), G2 (1 μL, 4 μM), and CbAgo (1 μL, 1 mg / mL) to Tris-HCl and MnCl2 buffer (pH=8, 4 μL), respectively, and pre-assembling at 37 °C for 15 minutes. Subsequently, the genomic DNA was denatured at 95 °C for 10 minutes to open the double-stranded structure. Then, 2 μL of genomic DNA (10 mg / mL) was added to each test tube. 8CFU / mL was added and incubated at 37°C for 20 minutes. Then, 5 μL of PS-R1 (white PS2μm-R1.1, 1 mg / mL; white PS3μm-R1.2, 1.5 mg / mL; blue PS3μm-R1.3, 3 mg / mL) and R2 (R2.1, 1 μL, 4 μM; R2.2, 1 μL, 4 μM; R2.3, 1 μL, 4 μM) were added to a 3 μL buffer solution (pH=8) and incubated at 37°C for 20 minutes. Finally, 5 μL of MNP-SA (500 μg / mL) was added and diluted with deionized water to a final volume of 50 μL. Magnetic separation was performed after incubation at 37°C for 20 minutes. The number of particles with different encoding PS microspheres was detected by microscopy, and decoding was performed using a computer vision-based AI reading system. L. monocytogenes , S. aureus and S. typhimurium The recoveries ranged from 83.33% to 112.05%, and the coefficients of variation ranged from 5.54% to 11.94%. Figure 26 This indicates that the detection method of the present invention achieves multiple detection and exhibits excellent performance even in complex samples.
[0090] Then, this method was used to detect pathogens in actual samples. Figure 27 Thirty fish meat samples and 30 clinical samples were selected for testing. The results showed that the detection results of this method were in good agreement with those of real-time quantitative polymerase chain reaction (qPCR) and plate counting. The procedure was in accordance with the following standards: SN / T 1870-2016 Detection Method for Foodborne Pathogens in Exported Foods - Real-time Fluorescent PCR Method; GB 4789.10-2016 National Food Safety Standard - Microbiological Examination of Food - Staphylococcus aureus Examination; GB 4789.4-2024 National Food Safety Standard - Microbiological Examination of Food - Salmonella Examination; and GB 4789.30-2025 National Food Safety Standard - Microbiological Examination of Food - Listeria monocytogenes Examination. The accuracy of this method reached 99% and 98% compared to the plate counting method and real-time fluorescent PCR method, respectively. Figure 28 ).
[0091] Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Anyone skilled in the art can make various modifications and alterations without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be determined by the claims.
Claims
1. A method for screening compositions for multiplex detection, characterized in that, The method includes the following steps: (1) Encoding DNA bases using "A", "T", "C", and "G" as character codes, set from left to right in the 5'-3' direction, and setting length and G / C content as basic parameters; (2) Inputting the target sequence, randomly selecting candidate gDNA1 from the target sequence according to the basic parameters, and displaying it in the 5'-3' direction; (3) Obtaining gDNA1 in step (2), obtaining similarity judgment through forward continuous similarity calculation and reverse continuous similarity calculation rules, and if the similarity is high, returning to (2) to re-select gDNA1; (4) Obtaining gDNA1 in step (3), setting 10nt bases in the 5'-3' direction and 6nt bases extending further to the 5' end of the target sequence, totaling 16nt bases, as candidate G1; setting 6nt bases in the 3'-5' direction and 10nt bases extending further to the 3' end of the target sequence, totaling 16nt bases, as candidate G1; nt bases are set as candidate G2; all G1 and G2 similarity judgments are obtained through forward continuous similarity calculation and reverse continuous similarity calculation rules. If the similarity is high, return to (3) to re-screen gDNA1; (5) gDNA1 obtained after verification in step (4) is obtained by changing its orientation in 3'-5' and randomly generating 6nt bases at the 3' end to obtain candidate R1. 16nt bases in the 3'-5' direction of R1 are candidate gDNA2. Candidate gDNA2 is obtained by changing its orientation in 3'-5' and extending the 3' end of the gDNA1 sequence by 6nt bases at the 3' end; (6) gDNA2 obtained in step (5) is obtained by obtaining similarity judgments through forward continuous similarity calculation and reverse continuous similarity calculation rules. If the similarity is high, return to (5) to re-screen R1. If it cannot be screened, (2) to re-screen gDNA1.
2. A composition, characterized in that, The composition comprises the following three groups of compositions: (1) nucleic acid compositions G1.1, G2.1, R1.1, and R2.1 for detecting Listeria monocytogenes, with nucleotide sequences as shown in SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, and SEQ ID NO.6, respectively; (2) nucleic acid compositions G1.2, G2.2, R1.2, and R2.2 for detecting Staphylococcus aureus, with nucleotide sequences as shown in SEQ ID NO.8, SEQ ID NO.9, SEQ ID NO.10, and SEQ ID NO.12, respectively; and (3) nucleic acid compositions G1.3, G2.3, R1.3, and R2.3 for detecting Salmonella, with nucleotide sequences as shown in SEQ ID NO.14, SEQ ID NO.15, SEQ ID NO.16, and SEQ ID NO.18, respectively.
3. The composition according to claim 2, characterized in that, R1.1, R1.2, and R1.3 are all mounted on the surface of polystyrene microspheres to obtain PS-R1.1, PS-R1.2, and PS-R1.
3. The amino acid sequences of PS-R1.1, PS-R1.2, and PS-R1.3 are as shown in SEQ ID NO.5, SEQ ID NO.12, and SEQ ID NO.17, respectively.
4. The composition according to claim 3, characterized in that, The polystyrene microspheres of PS-R1.1, PS-R1.2, and PS-R1.3 have particle sizes and colors of 2μm white, 3μm white, and 3μm blue, respectively.
5. A detection system for simultaneously detecting Staphylococcus aureus, Salmonella, and Listeria monocytogenes, characterized in that, The detection system contains the composition according to any one of claims 2 to 4.
6. The detection system according to claim 5, characterized in that, The detection system also contains Clostridium butyricum Ago protein and MNP-SA.
7. A reagent kit, characterized in that, The kit contains the composition according to any one of claims 2 to 4 or the detection system according to any one of claims 5 to 6.
8. A method for mesotemperature multiplexing based on CbAgo, characterized in that, The method involves using the detection system described in any one of claims 5 to 6 to detect Staphylococcus aureus, Salmonella, and Listeria monocytogenes.
9. The method according to claim 8, characterized in that, The method includes the following steps: (1) G1.1, G1.2, G1.3, G2.1, G2.2, and G2.3 were pre-assembled in Tris-HCl and MnCl2 buffer (pH=8, 4 μL) for 15 minutes at 37 °C; target genomic DNA was added and the mixture was treated at 95 °C for 10 minutes. (2) Add PS-R1.1, PS-R1.2 and PS-R1.3 to the system in step (1), and incubate at 37 °C for 20 minutes. Then add MNP-SA, incubate at 37 °C for 20 minutes, and perform magnetic separation to obtain a suspension. (3) Place the suspension from step (2) into the imaging readout system and perform digital decoding. The number of microspheres with different particle sizes and colors is associated with different target concentrations to characterize the content of Staphylococcus aureus, Salmonella and Listeria monocytogenes in the target to be tested.
10. The use of the composition according to any one of claims 2 to 4, or the detection system according to any one of claims 5 to 6, or the kit according to claim 7 in the in vitro detection of Staphylococcus aureus, Salmonella and Listeria monocytogenes.
